(Q34160761)

31 July 2017

1 reference

title

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies (English)

1 reference

31 July 2017

0 references

4

0 references

author name string

Daniel S Auld

series ordinal

1

1 reference

PubMed ID

12450488

31 July 2017

Tom J Kornecook

series ordinal

2

1 reference

PubMed ID

12450488

31 July 2017

Stéphane Bastianetto

series ordinal

3

1 reference

31 July 2017

1 October 2002

1 reference

31 July 2017

Progress in Neurobiology

1 reference

31 July 2017

68

1 reference

31 July 2017

3

1 reference

31 July 2017

209-245

1 reference

Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of physostigmine and scopolamine on recognition memory in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Scopolamine impairs recall of one-trial stimulus-reward association in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid induced increase in choline flux across PC12 cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Abnormal movements with donepezil in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

N-[3H]methylcarbamylcholine binding sites in the rat and human brain: relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Learning and memory in transgenic mice modeling Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The MAPK cascade is required for mammalian associative learning.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Potential role of muscarinic agonists in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cognitive functions of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Intact spatial learning following lesions of basal forebrain cholinergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Disruption of decrements in conditioned stimulus processing by selective removal of hippocampal cholinergic input.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Preserved cognitive skills in dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of Ginsenoside Rbi on Central Cholinergic Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galantamine: therapeutic effects beyond cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer patients show a sensitivity decrement over time on a tonic alertness task.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

1 reference

7 January 2021

Donepezil in treatment-resistant bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Transverse patterning reveals a dissociation of simple and configural association learning abilities in rats with 192 IgG-saporin lesions of the nucleus basalis magnocellularis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuron loss in APP transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A role for the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Selective removal of cholinergic neurons in the basal forebrain alters cued target detection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic receptors and cholinergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Brain acetylcholine: Increase after systematic choline administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic function and intellectual decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Unsolved problems in the cholinergic nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acetylcholine induces neuritic outgrowth in rat primary olfactory bulb cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic receptors in human brain: topography and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Physostigmine ameliorates the delusions of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Local infusion of scopolamine into intraparietal cortex slows covert orienting in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The amygdala: vigilance and emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Modelling Alzheimer's disease in multiple transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Donepezil: a review of its use in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Human memory and the cholinergic system. A relationship to aging?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Memory and cognitive function in the elderly. A preliminary trial of physostigmine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer transgenic mouse models come of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neural transplants as a treatment for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Prospects for pharmacological intervention in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Lecithin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Sustained cognitive improvement following treatment of Alzheimer's disease with donepezil.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Central cholinergic systems and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The organization and some projections of cholinergic neurons of the mammalian forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

NGF improves spatial memory in aged rodents as a function of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of aging and dementia upon recent visuospatial memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Animal and human memory dysfunctions associated with aging, cholinergic lesions, and senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Scopolamine effects on memory retention in mice: a model of dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Difference in toxicity of beta-amyloid peptide with aging in relation to nerve growth factor content in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Ageing: the cholinergic hypothesis of cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acetylcholinesterase inhibitors in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cortical projection patterns of the medial septum-diagonal band complex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system. I. Axon terminal region: hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Oestrogen and nerve growth factor - neuroprotection and repair in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Hippocampal synaptic transmission enhanced by low concentrations of nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinesterase inhibitors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Learning impairment and cholinergic deafferentation after cortical nerve growth factor deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinotoxic effects of beta-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of scopolamine on variable intertrial interval spatial alternation and memory in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Transgenic mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Semantic memory impairment in Alzheimer's disease: Failure of access or degraded knowledge?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Specific cholinergic destruction in the basal magnocellular nucleus and impaired passive avoidance behavior of rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Transgenic mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Tacrine, a reversible acetylcholinesterase inhibitor, induces myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic receptors in the brain: correlating physiology with function

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor treatment in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impaired phosphoinositide hydrolysis in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The cholinergic system in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

1 reference

7 January 2021

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Spermidine, a polyamine site agonist, attenuates working memory deficits caused by blockade of hippocampal muscarinic receptors and mGluRs in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Muscarinic M(1) agonists in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

High-affinity uptake of choline, a marker for cholinergic nerve terminals, is not specific in developing rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium-3 sensitive choline carriers: effects of a proteolytic degradation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The therapeutic potential of tacrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer Disease, Attention, and the Cholinergic System

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid1-40 inhibits electrically stimulated release of [3H]norepinephrine and enhances the internal calcium response to low potassium in rat cortex: prevention with a free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galantamine: additional benefits to patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotransmitter regulation of neuronal outgrowth, plasticity and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nucleus basalis magnocellularis and memory: differential effects of two neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Human nerve growth factor improves spatial memory in aged but not in young rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of excitotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on conditional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Synaptic plasticity and memory: an evaluation of the hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Inflammation, autotoxicity and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Scopolamine affects short-term memory but not inferior temporal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The memory deficits in Alzheimer-type dementia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Dissociable effects of AMPA-induced lesions of the vertical limb diagonal band of Broca on performance of the 5-choice serial reaction time task and on acquisition of a conditional visual discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Searching for models of Alzheimer's disease: a comparison of four amnestic treatments in two behavioral tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotrophic factor strategies for the treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Intravenous nicotine in Alzheimer's disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid protein-induced Alzheimer's disease animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Working memory failure by combined blockade of muscarinic and beta-adrenergic transmission in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Scopolamine impairs performance of a place and cue task in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acetylcholine as a regulator of neurite outgrowth and motility in cultured embryonic mouse spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Affective modulation of multiple memory systems

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Visuospatial attention in dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Selective impairment of spatial attention during visual search in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuronal nicotinic receptors in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Characterization of the acetylcholine-reducing effect of the amyloid-beta peptide in mouse SN56 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acetylcholine and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Attention and executive deficits in Alzheimer's disease. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Necropsy evidence of central cholinergic deficits in senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of the potassium channel blockers, apamin and 4-aminopyridine, on scopolamine-induced deficits in the delayed matching to position task in rats: a comparison with the cholinesterase inhibitor E2020.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Mutant genes in familial Alzheimer's disease and transgenic models

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A mouse model for Down syndrome exhibits learning and behaviour deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

From arousal to cognition: the integrative position of the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neuropsychology--dementia and affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic activity and amyloid precursor protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta-amyloid peptides inhibit acetylcholine release from cholinergic presynaptic nerve endings isolated from an electric ray.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Beta(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galantamine: a review of its use in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Development of high affinity choline uptake and associated acetylcholine synthesis in the rat fascia dentata

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Transgenic approaches to model Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Review of the acetylcholinesterase inhibitor galanthamine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Long-term basal forebrain cholinergic-rich grafts derived from trisomy 16 mice do not develop beta-amyloid pathology and neurodegeneration but demonstrate neuroinflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of oral physostigmine in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

1 reference

7 January 2021

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Postsynaptic targets of GABAergic hippocampal neurons in the medial septum-diagonal band of broca complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Short-term control of the synthesis of acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Basal forebrain lesions in monkeys disrupt attention but not learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galanin inhibits acetylcholine release from rat cerebral cortex via a pertussis toxin-sensitive G(i)protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of scopolamine on radial maze performance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Donepezil improves symptoms of delirium in dementia: implications for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

The nucleus basalis magnocellularis cholinergic system: one hundred years of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer disease: plaques, tangles, and the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic acetylcholine binding sites in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autobiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Metrifonate: a new agent for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Cholinergic strategies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential effects of scopolamine on working and reference memory of rats in the radial maze

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Suppressive action produced by beta-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Role of the cholinergic system in the regulation of neurotrophin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Turning of nerve growth cones induced by neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Intact spatial learning in both young and aged rats following selective removal of hippocampal cholinergic input.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Interactions between 192-IgG saporin and intraseptal cholinergic and GABAergic drugs: role of cholinergic medial septal neurons in spatial working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Different effects on learning ability after injection of the cholinergic immunotoxin ME20.4IgG-saporin into the diagonal band of Broca, basal nucleus of Meynert, or both in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

Central cholinergic involvement in working memory: effects of scopolamine on continuous nonmatching and discrimination performance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2802%2900079-5

7 January 2021

10.1016/S0301-0082(02)00079-5

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12450488